Angiotensin System Inhibitors and Survival in Patients With Metastatic Renal Cell Carcinoma Treated With VEGF-targeted Therapy: A Pooled Secondary Analysis of Clinical Trials

International Journal of Cancer - United States
doi 10.1002/ijc.29972
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Outcomes of Patients With Metastatic Renal Cell Carcinoma Treated With Targeted Therapy After Immuno-Oncology Checkpoint Inhibitors

European urology oncology
OncologyRadiologyUrologyNuclear MedicineImagingSurgery
2019English

Mp03-08 Comprehensive Analysis and Validation of Contemporary Survival Prognosticators in Patients With Metastatic Renal Cell Carcinoma Treated With Targeted Therapy

Journal of Urology
Urology
2016English

Clinical Impact of Targeted Therapies in Patients With Metastatic Clear-Cell Renal Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2014English

CT Patterns of Organizing Pneumonia in Patients Treated With VEGF/mTOR Inhibitors for Metastatic Renal Cell Cancer: An Observational Study

Acta Radiologica Open
2017English

Survival Analyses of Patients With Metastatic Renal Cancer Treated With Targeted Therapy With or Without Cytoreductive Nephrectomy: A National Cancer Data Base Study

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2016English

Survival of Patients Receiving Systematic Therapy for Metachronous or Synchronous Metastatic Renal Cell Carcinoma: A Retrospective Analysis

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Real Life Progression Free Survival and Treatment Patterns for Patients With Metastatic Renal Cell Carcinoma Treated With Targeted Therapies in France: Analysis of Ims RWD Oncology Cross-Sectional Survey Data

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

A Pilot Study of Antiangiogenic Therapy With Bevacizumab and Thalidomide in Patients With Metastatic Renal Cell Carcinoma

Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer ResearchAllergyImmunologyPharmacology
2004English

Survival of Patients With Advanced or Metastatic Renal Cell Carcinoma in Routine Practice Differs From That in Clinical Trials—Analyses From the German Clinical RCC Registry

Clinical Genitourinary Cancer
OncologyUrology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy